To view this email as a web page, click here.
 
PHARMACISTS' REPORT
 
The 10 Best—and Worst—States for Vaccinations
image description here Which states are the most likely to vaccinate—and which ones are most likely to skip?

More
 
Biosimilars Need Access and Cost Examinations
image description here Biologic medicines could lower spending by $153 billion by 2023.

More
 
FDA Approves Canagliflozin Indication Expansion
image description here Now approved for risk reductions in patients with type 2 diabetes mellitus.

More
 
ADVERTISEMENT
100+ Pharmacies have Implemented Pharmacist eCare Plans with PrimeRx
PrimeRx users have come to realize the simplicity of the pharmacy management system in developing and maintaining their pharmacy eCare plans. Download whitepaper to read more about the PrimeRx eCare plan functionality! Learn more
 
Read More
 
5 Pipeline Drugs to Watch
Fear Motivates Vaccinations, Study Finds
Upcoming Vaccinations in the Pipeline
Support Staff Training Resources
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.